Sort   by:  
 Page size 
UnknownGlycosaminoglycan Binding and Non-Endocytic Membrane Translocation of Cell-Permeable Octaarginine Monitored by Real-Time In-Cell NMR Spectroscopy.
Not available
S-EPMC5490399 | biostudies-literature
UnknownEffect of hydrophobic moment on membrane interaction and cell penetration of apolipoprotein E-derived arginine-rich amphipathic α-helical peptides.
Not available
S-EPMC8943082 | biostudies-literature
UnknownEstimation of Clearance and Bioavailability of Therapeutic Monoclonal Antibodies from Only Subcutaneous Injection Data in Humans Based on Comprehensive Analysis of Clinical Data.
Not available
S-EPMC8505369 | biostudies-literature
UnknownQuantitative Prediction of Human Pharmacokinetics for Fc-Engineered Therapeutic Monoclonal Antibodies With Increased FcRn Binding Mutations After Subcutaneous Injection.
Not available
S-EPMC12824526 | biostudies-literature
UnknownRecent Advances in Translational Pharmacokinetics and Pharmacodynamics Prediction of Therapeutic Antibodies Using Modeling and Simulation.
Not available
S-EPMC9145563 | biostudies-literature
UnknownPrediction of human pharmacokinetics of Fc-engineered therapeutic monoclonal antibodies using human FcRn transgenic mice.
Not available
S-EPMC11938312 | biostudies-literature
UnknownNXT007 enhances <i>in vitro</i> coagulation potential in the coexistence of emicizumab in hemophilia A through distinct complex formation.
Not available
S-EPMC12664447 | biostudies-literature
UnknownIdentification of human IgG1 variant with enhanced FcRn binding and without increased binding to rheumatoid factor autoantibody.
Not available
S-EPMC5524163 | biostudies-literature
UnknownEngineered antibody Fc variant with selectively enhanced FcγRIIb binding over both FcγRIIa(R131) and FcγRIIa(H131).
Not available
S-EPMC3785249 | biostudies-literature
UnknownIn vivo imaging with two-photon microscopy to assess the tumor-selective binding of an anti-CD137 switch antibody.
Not available
S-EPMC8941111 | biostudies-literature
Sort   by:  
 Page size